Sean Escola

Sean is a multidisciplinary expert at the intersection of neuroscience, AI, and psychiatry. Currently, he serves as Neurotech and NeuroAI Lead at Protocol Labs. He co-founded Herophilus, a biotech company focused on stem cell organoids and machine learning for drug discovery, which was acquired by Genentech in 2023 after raising $30M and building a team of over 40 scientists. Previously, he led a computational neuroscience lab at Columbia University, exploring neural circuits, motor control, learning, and psychopathology. Sean also co-founded Neuromatch, a global nonprofit dedicated to democratizing science through education and open publishing, raising $2M in philanthropy. Additionally, he maintains a small private practice as a clinical psychiatrist.